News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter

Arcus Medical Receives Reimbursement Approval from the Prescription Pricing Authority in the United Kingdom

4/15/2009 12:16:40 PM

Charlotte, North Carolina, April 15, 2009 – Arcus Medical, LLC (Arcus), a leading innovator and manufacturer of patented medical devices, announced today that its afex® brand of products for management of male incontinence has been approved for reimbursement by the Prescription Pricing Authority (PPA) in the United Kingdom.

Sales and distribution of afex® products will be led by Mr. Darren Breen of iMEDicare, Ltd. in the UK. Since receiving CE Certification for afex® in 2008, the UK market was selected as the strategic center for developing scalable sales and distribution channels to additional EU countries.

“We estimate that there are approximately 3 million men in the UK managing urinary incontinence. The market potential for afex® in the UK is very compelling and we look forward to developing the UK market with iMEDicare,” said Michael LaCount, President and CEO of Arcus Medical. “Since afex® has been approved for reimbursement by the PPA, afex® can compete with incumbent products primarily on the basis of innovation. We are confident that incontinent men in the UK will react very favorably to afex® and we have every confidence that Mr. Breen can effectively build a robust strategic sales channel for afex® in the UK.”

Mr. Mark Miskie, Arcus founder and its Chief Operating Officer added, “Gaining PPA approval in the UK represents another significant milestone for Arcus Medical as we continue to build our core strategic capabilities and expand our global reach to help both patients and caregivers effectively manage incontinence every day.”

About Arcus Medical

Arcus is dedicated to its mission of improving the quality of life and care for patients and their caregivers around the world. Since its founding in 2004, Arcus has advanced its pipeline of patented and proprietary medical device technologies for management of incontinence to the commercial markets. Arcus markets its innovative products under the afex®, Folex®, and Provent™ brands.

The afex® brand features a patented, non-adhesive receptacle that fits into a comfortable pair of cotton boxer-briefs and couples to a durable, secured collection bag offering an innovative and discreet solution for active, mobility-assisted, or sedentary men with incontinence.

Folex® branded products are specifically designed for extended, unobtrusive comfort and easy connection and release for patients using Foley catheters.

Provent™ branded briefs and pads feature a patented triple layer composite technology which offers superior ability to pull and lock wetness away from the skin while providing breathability for effective wetness protection.

For more information, please visit its website at

Read at

comments powered by Disqus